Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families.
Mahtani MM, Widén E, Lehto M, Thomas J, McCarthy M, Brayer J, Bryant B, Chan G, Daly M, Forsblom C, Kanninen T, Kirby A, Kruglyak L, Munnelly K, Parkkonen M, Reeve-Daly MP, Weaver A, Brettin T, Duyk G, Lander ES, Groop LC. Mahtani MM, et al. Among authors: bryant b. Nat Genet. 1996 Sep;14(1):90-4. doi: 10.1038/ng0996-90. Nat Genet. 1996. PMID: 8782826
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib.
Mulligan G, Mitsiades C, Bryant B, Zhan F, Chng WJ, Roels S, Koenig E, Fergus A, Huang Y, Richardson P, Trepicchio WL, Broyl A, Sonneveld P, Shaughnessy JD Jr, Bergsagel PL, Schenkein D, Esseltine DL, Boral A, Anderson KC. Mulligan G, et al. Among authors: bryant b. Blood. 2007 Apr 15;109(8):3177-88. doi: 10.1182/blood-2006-09-044974. Epub 2006 Dec 21. Blood. 2007. PMID: 17185464 Free article. Clinical Trial.
High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone.
Zhan F, Barlogie B, Mulligan G, Shaughnessy JD Jr, Bryant B. Zhan F, et al. Among authors: bryant b. Blood. 2008 Jan 15;111(2):968-9. doi: 10.1182/blood-2007-10-119321. Blood. 2008. PMID: 18182586 Free PMC article. No abstract available.
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ, Van Wier S, Tiedemann R, Shi CX, Sebag M, Braggio E, Henry T, Zhu YX, Fogle H, Price-Troska T, Ahmann G, Mancini C, Brents LA, Kumar S, Greipp P, Dispenzieri A, Bryant B, Mulligan G, Bruhn L, Barrett M, Valdez R, Trent J, Stewart AK, Carpten J, Bergsagel PL. Keats JJ, et al. Among authors: bryant b. Cancer Cell. 2007 Aug;12(2):131-44. doi: 10.1016/j.ccr.2007.07.003. Cancer Cell. 2007. PMID: 17692805 Free PMC article.
Retronychia: the importance of proper footwear.
Riopelle AM, Rajanala S, Khan S, Kosuru SB, Bryant B, Adigun CG, Kuchnir L. Riopelle AM, et al. Among authors: bryant b. Dermatol Online J. 2024 Mar 15;30(1). doi: 10.5070/D330163282. Dermatol Online J. 2024. PMID: 38762854 Review.
Predictors of Substance Use Initiation by Early Adolescence.
Green R, Wolf BJ, Chen A, Kirkland AE, Ferguson PL, Browning BD, Bryant BE, Tomko RL, Gray KM, Mewton L, Squeglia LM. Green R, et al. Among authors: bryant be. Am J Psychiatry. 2024 May 1;181(5):423-433. doi: 10.1176/appi.ajp.20230882. Am J Psychiatry. 2024. PMID: 38706327
Endometrial Cancer in a Family With RAD51D Gene Mutation.
Gilmore B, Logan L, McKinnon W, Everett E, Bryant BH. Gilmore B, et al. Among authors: bryant bh. Int J Gynecol Pathol. 2024 Mar 25. doi: 10.1097/PGP.0000000000000981. Online ahead of print. Int J Gynecol Pathol. 2024. PMID: 38661557
481 results